Save time and get answers to complex questions with AI chat
Brenzavvy discontinuation?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?Norcuron generic name?Is januvia still on the market?Dabrafenib and trametinib price?
See the DrugPatentWatch profile for Nuedexta
Nuedexta is prescribed to treat pseudobulbar affect (PBA), also called pathological laughing and crying—a condition where a person has sudden, uncontrollable episodes of laughing or crying that don’t match how they actually feel.
It’s used in people with neurologic conditions that can be associated with PBA, such as: - Multiple sclerosis (MS) - Amyotrophic lateral sclerosis (ALS) - Other neurologic disorders where PBA occurs
Nuedexta combines: - Dextromethorphan, which affects brain signaling involved in emotional expression - Quinidine, which helps keep dextromethorphan levels high enough to work consistently
No sources were provided with your question, and I don’t have enough information here to cite specific claims from DrugPatentWatch.com or other references. If you share the text/source you’re working from, I can answer using only that material.
Other Questions About Nuedexta :